The call was made during a one-day workshop organised by the National Agency for the Control of HIV/AIDS (NACA), in ...

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

Men with HIV and severe sleep-disordered breathing experience the greatest sleep disruption, with lower efficiency, more light sleep, and unstable sleep stages.

Now, the fight against HIV/AIDS is not just about governments and global health organisations anymore; it is a deeply personal one. And it is all about the choices you make, the conversations you have ...

In these uncertain, volatile, and unprecedented times, the role of science is more important than ever. Scientific advances that benefit humanity and ensure planetary sustainability for current and ...

Patients with and without HIV had similar 1- and 3-year survival outcomes following kidney transplantation, however, 5-year survival outcomes differed significantly.

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

Overall, tailoring an HIV treatment regimen to individuals’ clinical and social context can help mitigate the persistent barriers to care access. Switching treatment is not just a clinical decision ...

Len is for HIV-negative people to try and stop them from getting HIV…when you get an injection, the contents of the injection ...

A second study presented at IDWeek showed that shingles vaccination decreases the risk for death and heart disease — this time among people living with HIV.“Shingles is usually thought of as a painful ...